PubMed:38154551 / 1807-1975 JSONTXT

Annnotations TAB JSON ListView MergeView

    HP-phenotype

    {"project":"HP-phenotype","denotations":[{"id":"T24","span":{"begin":89,"end":103},"obj":"Phenotype"},{"id":"T25","span":{"begin":89,"end":91},"obj":"Phenotype"},{"id":"T26","span":{"begin":105,"end":107},"obj":"Phenotype"},{"id":"T27","span":{"begin":110,"end":132},"obj":"Phenotype"},{"id":"T28","span":{"begin":134,"end":136},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"HP:4000041"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"HP:4000041"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"HP:4000041"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"HP:0012578"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"HP:0012578"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T26","span":{"begin":89,"end":103},"obj":"Disease"},{"id":"T27","span":{"begin":89,"end":91},"obj":"Disease"},{"id":"T28","span":{"begin":105,"end":107},"obj":"Disease"},{"id":"T29","span":{"begin":110,"end":132},"obj":"Disease"},{"id":"T30","span":{"begin":134,"end":136},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0019439"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0019439"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0019439"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005376"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005376"}],"text":"Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls."}

    GlyCosmos15-HP

    {"project":"GlyCosmos15-HP","denotations":[{"id":"T24","span":{"begin":89,"end":103},"obj":"Phenotype"},{"id":"T25","span":{"begin":89,"end":91},"obj":"Phenotype"},{"id":"T26","span":{"begin":105,"end":107},"obj":"Phenotype"},{"id":"T27","span":{"begin":110,"end":132},"obj":"Phenotype"},{"id":"T28","span":{"begin":134,"end":136},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"HP:4000041"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"HP:4000041"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"HP:4000041"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"HP:0012578"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"HP:0012578"}],"text":"Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls."}

    GlyCosmos15-MONDO

    {"project":"GlyCosmos15-MONDO","denotations":[{"id":"T24","span":{"begin":89,"end":103},"obj":"Disease"},{"id":"T25","span":{"begin":89,"end":91},"obj":"Disease"},{"id":"T26","span":{"begin":105,"end":107},"obj":"Disease"},{"id":"T27","span":{"begin":110,"end":132},"obj":"Disease"},{"id":"T28","span":{"begin":134,"end":136},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"MONDO:0019439"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"MONDO:0019439"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"MONDO:0019439"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"MONDO:0005376"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"MONDO:0005376"}],"namespaces":[{"prefix":"MONDO","uri":"http://purl.obolibrary.org/obo/MONDO_"}],"text":"Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T17","span":{"begin":0,"end":168},"obj":"Sentence"}],"text":"Here, we performed a comparative urinary omics analysis between recently diagnosed renal AA amyloidosis (AA), membranous nephropathy (MN) patients and healthy controls."}